Cg Oncology Inc. [CGON] stock prices are down -1.33% to $38.50 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CGON shares have gain 0.29% over the last week, with a monthly amount glided 10.00%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, March 2024, CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting. In a post published today on Yahoo Finance, – New 12-month data from the Phase 3 BOND-003 trial to be featured in an oral presentation in the Paradigm-shifting, Practice-changing Clinical Trials in Urology plenary session -.
From an analyst’s perspective:
Cg Oncology Inc. [NASDAQ: CGON] stock has seen the most recent analyst activity on February 20, 2024, when Morgan Stanley initiated its Overweight rating and assigned the stock a price target of $55. Previously, Goldman started tracking the stock with Neutral rating on February 20, 2024, and set its price target to $42. On February 20, 2024, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $75 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $75 on February 14, 2024.
The stock price of Cg Oncology Inc. [CGON] has been fluctuating between $28.55 and $50.23 over the past year. Cg Oncology Inc. [NASDAQ: CGON] shares were valued at $38.50 at the most recent close of the market.
Analyzing the CGON fundamentals
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 37.67 points at the first support level, and at 36.85 for the second support level. However, for the 1st resistance point, the stock is sitting at 38.94, and for the 2nd resistance point, it is at 39.38.
Ratios To Look Out For
It’s worth pointing out that Cg Oncology Inc. [NASDAQ:CGON]’s Current Ratio is 13.62. On the other hand, the Quick Ratio is 13.62.
Transactions by insiders
Recent insider trading involved Decheng Capital Global Life Sc, 10% Owner, that happened on Jan 29 ’24 when 0.4 million shares were purchased. Director, Song Hong Fang completed a deal on Jan 29 ’24 to buy 0.26 million shares. Meanwhile, CFO & Secretary Roche Corleen M. bought 2000.0 shares on Jan 29 ’24.
